Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Vercauteren, Jurgen" or (type any "bookEditor journalEditor issueEditor" and editor="Verc...

Add to list
- Journal Article
- A1
- open access
Patterns of transmitted HIV drug resistance in Europe vary by risk group

Dineke Frentz, David van de Vijver, Ana Abecasis, Jan Albert, Osamah Hamouda, Louise Jørgensen, Claudia Kücherer, Daniel Struck, Jean-Claude Schmit, Jurgen Vercauteren, et al.

(2014) PLOS ONE. 9(4).
Add to list
- Journal Article
- A1
- open access
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

Dineke Frentz, David AMC Van de Vijver, Ana B Abecasis, Jan Albert, Osamah Hamouda, Louise B Jørgensen, Claudia Kücherer, Daniel Struck, Jean-Claude Schmit, Jurgen Vercauteren, et al.

(2014) BMC INFECTIOUS DISEASES. 14.
Add to list
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials

John T Maringwa, Chantal Quinten, Madeleine King, Jolie Ringash, David Osoba, Corneel Coens, Francesca Martinelli, Jurgen Vercauteren, Charles S Cleeland, Henning Flechtner, et al.

(2011) SUPPORTIVE CARE IN CANCER. 19(11). p.1753-1760
Add to list
Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006

Jurgen Vercauteren, Inge Derdelinckx, Andre Sasse, Marleen Bogaert, Helga Ceunen, Ann De Roo, Stephane De Wit, Koen Deforche, Fedoua Echahidi, Katrien Fransen, et al.

(2008) AIDS RESEARCH AND HUMAN RETROVIRUSES. 24(3). p.355-362

Academic Bibliography

Patterns of transmitted HIV drug resistance in Europe vary by risk group

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006

Contents

Support

Contact